Approval for first drug designed to treat PPD

The United States Food and Drug Administration has recently approved the first-ever drug to fight postpartum depression (PPD). The new drug, brexanolone, is taken intravenously and over the course of 60 hours. Women tend to see relief within 48 hours of treatment.

This fast-acting drug isn’t cheap, but to many women its price tag is worth it. Each dosage vile is around $7,000, with the total treatment running around $30,000 before insurance, plus time spent in the hospital.

Sage Therapeutics, the company behind the drug, is working on a pill version that will be less expensive.

– Katie Connor, 360 Media, Inc.